- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Melrose Today
By the People, for the People
Hormel Sells Whole-Bird Turkey Unit To Chase Steadier Growth
Hormel Foods reports preliminary Q1 2026 results, projects $3B in sales and 2% organic growth.
Published on Feb. 21, 2026
Got story updates? Submit your updates here. ›
Hormel Foods Corp. has agreed to sell its whole-bird turkey business to Life-Science Innovations as part of a broader strategy to strengthen its portfolio by emphasizing more stable, value-added protein products. Hormel reported preliminary fiscal first-quarter 2026 results, projecting net sales of around $3 billion with a 2% organic net sales growth.
Why it matters
Hormel's divestment from its whole-bird turkey business is part of the company's efforts to refine its business model and reduce risks from volatile commodity-driven segments. By focusing on value-added products, Hormel aims to support sustained profitability and growth.
The details
Hormel will sell its production and transportation assets in Minnesota, including the Melrose whole-bird facility and the Swanville feed mill, to Life-Science Innovations (LSI). LSI will also take over supply agreements with independent turkey growers and maintain co-manufacturing operations with Hormel until the end of fiscal 2026 to facilitate a smooth transition. The JENNIE-O brand remains central to Hormel's growth strategy and continues to be a significant revenue source.
- Hormel reported preliminary fiscal first-quarter 2026 results on Tuesday.
- The sale to Life-Science Innovations is expected to close by the end of Hormel's second fiscal quarter.
The players
Hormel Foods Corp.
A food company that produces a variety of meat and food products, including the JENNIE-O turkey brand.
Life-Science Innovations (LSI)
The company that is purchasing Hormel's whole-bird turkey business assets and production facilities.
John Ghingo
The president of Hormel Foods.
Jeff Ettinger
The interim chief executive officer of Hormel Foods.
What they’re saying
“This transaction is an important next step in our evolution. With a more focused turkey portfolio, we will continue strengthening the value-added aspects of our JENNIE-O business. We look forward to working with LSI to ensure a smooth transition for our team members, customers, consumers, and suppliers.”
— John Ghingo, President, Hormel Foods (Benzinga)
“They reflect a solid start to the year, are aligned with our expectations and give us confidence that we are focused on the right initiatives to return Hormel Foods to profitable growth.”
— Jeff Ettinger, Interim Chief Executive Officer, Hormel Foods (Benzinga)
What’s next
Hormel will reaffirm its fiscal 2026 guidance, targeting 2-3% organic net sales growth and 5-7% operating profit growth, at the Consumer Analyst Group of New York conference.
The takeaway
Hormel's decision to sell its whole-bird turkey business and focus on value-added protein products is part of the company's broader strategy to strengthen its portfolio and reduce risks from volatile commodity-driven segments. This shift aims to support Hormel's long-term profitability and growth.

